New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

Details for Australian Patent Application No. 2007260267 (hide)

Owner UCB Pharma GmbH

Inventors Meese, Claus

Agent Griffith Hack

Pub. Number AU-B-2007260267

PCT Pub. Number WO2007/144097

Priority 06012052.4 12.06.06 EP

Filing date 6 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 6 September 2012

International Classifications

C07D 311/20 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/353

Event Publications

23 October 2008 PCT application entered the National Phase

  PCT publication WO2007/144097 Priority application(s): WO2007/144097

30 August 2012 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH

6 September 2012 Application Accepted

  Published as AU-B-2007260267

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260270-Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents

2007260252-Reactor with a controlled thermal gradient for the production of pure hydrogen